ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
theplew
|
9.4K |
2.7M |
3 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
theplew
|
549 |
169K |
5 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
169K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Colitis Indication
|
|
theplew
|
19 |
6.9K |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
19
|
6.9K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Colitis Indication
|
|
theplew
|
19 |
6.9K |
4 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
19
|
6.9K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB is back on its Fast and Furious SUCCESS Track - We Need these Types of SUCCESS!
|
|
theplew
|
18 |
5.0K |
3 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
18
|
5.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
theplew
|
362 |
116K |
6 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
116K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
rexlemestrocel-L in the treatment of chronic low back pain (CLBP)
|
|
theplew
|
24 |
7.1K |
5 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
24
|
7.1K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
theplew
|
1.3K |
543K |
13 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
theplew
|
1.3K |
543K |
25 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
theplew
|
1.3K |
543K |
4 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
theplew
|
1.3K |
543K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
theplew
|
400 |
148K |
9 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
148K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
theplew
|
3.4K |
1.1M |
12 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
theplew
|
3.4K |
1.1M |
15 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
5 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
5 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
theplew
|
3.4K |
1.1M |
87 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
87
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
15 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
43 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
43
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
theplew
|
3.4K |
1.1M |
9 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
theplew
|
202 |
84K |
3 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
202
|
84K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
27 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
17K
|
6.6M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
9 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
theplew
|
87 |
45K |
63 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
87
|
45K
|
63
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
theplew
|
274 |
119K |
12 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
274
|
119K
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
theplew
|
400 |
148K |
6 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
400
|
148K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
|
|
theplew
|
217 |
69K |
4 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
217
|
69K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
8 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
17K
|
6.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Second Quarter Financial Results Webcast
|
|
theplew
|
56 |
18K |
12 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
56
|
18K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
theplew
|
111 |
40K |
25 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
40K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
theplew
|
144 |
47K |
0 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
47K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
theplew
|
144 |
47K |
1 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
47K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
theplew
|
144 |
47K |
2 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
47K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
theplew
|
144 |
47K |
4 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
47K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
theplew
|
4.7K |
1.0M |
3 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
4.7K
|
1.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
theplew
|
914 |
286K |
1 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
914
|
286K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
theplew
|
914 |
286K |
1 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
914
|
286K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
theplew
|
914 |
286K |
8 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
914
|
286K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
theplew
|
4.7K |
1.0M |
33 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
4.7K
|
1.0M
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
theplew
|
4.7K |
1.0M |
13 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
4.7K
|
1.0M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
6 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
17K
|
6.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
29 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
17K
|
6.6M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
theplew
|
9.4K |
2.7M |
10 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
9 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Extension of Undrawn US$30 million Facility
|
|
theplew
|
71 |
19K |
10 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
71
|
19K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
theplew
|
17K |
6.6M |
27 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
17K
|
6.6M
|
27
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
theplew
|
304 |
91K |
1 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
304
|
91K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA does not over-rule positive ODAC decisions
|
|
theplew
|
161 |
78K |
2 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
161
|
78K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FDA does not over-rule positive ODAC decisions
|
|
theplew
|
161 |
78K |
19 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
161
|
78K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
FDA does not over-rule positive ODAC decisions
|
|
theplew
|
161 |
78K |
3 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
161
|
78K
|
3
|
|